Anika Therapeutics (ANIK) Capital Expenditures (2010 - 2026)
Anika Therapeutics (ANIK) posted quarterly Capital Expenditures of $1.4 million for Q2 2026, down 1.23% year-over-year from $1.5 million in Q2 2025, and up 1.26% quarter-over-quarter from $1.4 million in Q1 2026.
Anika Therapeutics (ANIK) Capital Expenditures (2010 - 2026) Analysis & Trends
Anika Therapeutics (ANIK) has reported Capital Expenditures for 17 consecutive years, with $1.4 million the latest figure, recorded in Q2 2026.
- In Q2 2026, Capital Expenditures fell 1.23% year-over-year to $1.4 million; the TTM figure through Jun 2026 stood at $5.4 million (down 20.53% YoY), while the FY2025 annual figure was $6.8 million, down 11.74% from the prior year.
- Capital Expenditures advanced to $1.4 million in Q2 2026 per ANIK's latest filing, from $1.4 million in the prior quarter.
- Across five years, Capital Expenditures topped out at $3.4 million in Q2 2024 and bottomed at $648000.0 in Q4 2025.
- Historically, Capital Expenditures has averaged $1.7 million across 5 years, with a median of $1.5 million in 2023.
- Annual changes were most pronounced in 2024 — Capital Expenditures soared 133.56% — and 2025, when it plunged 56.89%.
- Anika Therapeutics' Capital Expenditures stood at $2.5 million in 2022, then declined by 27.24% to $1.8 million in 2023, then slipped by 28.97% to $1.3 million in 2024, then slumped by 50.42% to $648000.0 in 2025, then soared by 123.61% to $1.4 million in 2026.
- Business Quant data shows ANIK's Capital Expenditures at $1.4 million in Q2 2026, $1.4 million in Q1 2026, and $648000.0 in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.51 Bn | 43.55 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.52 Bn | 39.86 Bn | 2.15 Bn | 104.00 Mn |
| 3 | Zoetis | 32.43 Bn | 30.75 Bn | 1.05 Bn | 117.00 Mn |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn | -337.60 Mn |
| 5 | United Therapeutics | 21.87 Bn | 19.21 Bn | 683.80 Mn | 108.00 Mn |
| 6 | Viatris | 18.98 Bn | 18.09 Bn | 1.46 Bn | 52.80 Mn |
| 7 | Neurocrine Biosciences | 15.43 Bn | 15.04 Bn | 935.80 Mn | 7.80 Mn |
| 8 | Elanco Animal Health | 12.02 Bn | 11.49 Bn | 798.00 Mn | 33.00 Mn |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - | - |
| 10 | Anika Therapeutics | 290.13 Mn | 251.72 Mn | 21.24 Mn | 1.45 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1.45 Mn |
| Jun 30, 2026 | 1.45 Mn |
| Mar 31, 2026 | 1.43 Mn |
| Mar 31, 2026 | 1.43 Mn |
| Dec 31, 2025 | 648,000.00 |
| Dec 31, 2025 | 648,000.00 |
| Sep 30, 2025 | 1.89 Mn |
| Sep 30, 2025 | 1.89 Mn |
| Jun 30, 2025 | 1.47 Mn |
| Jun 30, 2025 | 1.47 Mn |
| Mar 31, 2025 | 2.82 Mn |
| Mar 31, 2025 | 2.82 Mn |
| Dec 31, 2024 | 1.31 Mn |
| Dec 31, 2024 | 1.31 Mn |
| Sep 30, 2024 | 1.22 Mn |
| Sep 30, 2024 | 1.22 Mn |
| Jun 30, 2024 | 3.40 Mn |
| Jun 30, 2024 | 3.40 Mn |
| Mar 31, 2024 | 1.81 Mn |
| Mar 31, 2024 | 1.81 Mn |